Cargando…

Urinary N telopeptide levels in predicting the anti-nociceptive responses of zoledronic acid and paclitaxel in a rat model of bone metastases

The present study investigated the hypothesis that urinary levels of N telopeptide (NTx) can be used to predict the anti-nociceptive responses of zoledronic acid and paclitaxel on bone metastases in a rat model. Rats were implanted with intra-femur Walker 256 carcinoma cells or control solution, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	GUI, QI, XU, CHENGCHENG, LI, DAPENG, ZHUANG, LIANG, XIA, SHU, YU, SHIYING
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526072/ https://www.ncbi.nlm.nih.gov/pubmed/26081451 http://dx.doi.org/10.3892/mmr.2015.3948

Ejemplares similares

Urinary N-telopeptide: The New Diagnostic Test for Osteoporosis
por: Ganesan, Ganesan Ram, et al.
Publicado: (2019)

Significant pain relief with loading dose zoledronic acid in bone metastases is only seen in patients with elevated initial serum C telopeptide (CTX)
por: Dekoninck, J, et al.
Publicado: (2011)

Urinary N‐Telopeptide as Predictor of Onset of Menopause‐Related Bone Loss in Pre‐ and Perimenopausal Women
por: Shieh, Albert, et al.
Publicado: (2018)

Measurement of Urinary N-Telopeptides and Serum C-Telopeptides from Type I Collagen Using a Lateral Flow-Based Immunoassay
por: Lee, Kyoung Min, et al.
Publicado: (2012)

Serum cross-linked N-telopeptide of type I collagen for the diagnosis of bone metastases from solid tumours in the Chinese population: Meta-analysis
por: Zhang, Yudong, et al.
Publicado: (2016)

THE SEROLOGIC SPECIFICITY OF TROPOCOLLAGEN TELOPEPTIDES
por: Davison, Peter F., et al.
Publicado: (1967)

Elevated N-telopeptide as a potential diagnostic marker for bone metastasis in lung cancer: A meta-analysis
por: Liu, Boxuan, et al.
Publicado: (2017)

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases
por: LI, FENQIANG, et al.
Publicado: (2014)

N-telopeptide as a potential diagnostic and prognostic marker for bone metastasis in human cancers: A meta-analysis
por: Li, Linlin, et al.
Publicado: (2023)

N-terminal telopeptides of type I collagen and bone mineral density for early diagnosis of nonunion: An experimental study in rabbits
por: Lin, Jian-Ping, et al.
Publicado: (2016)

Meta-analysis of urinary C-terminal telopeptide of type II collagen as a biomarker in osteoarthritis diagnosis
por: Huang, Mingjian, et al.
Publicado: (2017)

Utility of C-terminal Telopeptide in Evaluating Levothyroxine Replacement Therapy-Induced Bone Loss
por: Christy, Alap L., et al.
Publicado: (2014)

Maternal type 1collagen N-terminal telopeptide levels in severe hyperemesis gravidarum
por: Sahin, E., et al.
Publicado: (2018)

Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone density loss in patients with Crohn disease
por: Ishida, Natsuki, et al.
Publicado: (2021)

Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases
por: Quattrocchi, Carlo C., et al.
Publicado: (2012)

Plasma levels of N-telopeptide of Type I collagen in periodontal health, disease and after treatment
por: Aruna, Ganganna
Publicado: (2016)

Serum N-terminal telopeptide of type I collagen as an early marker of fracture nonunion in rabbits
por: Lin, Jian-Ping, et al.
Publicado: (2016)

Chinese Bone Turnover Marker Study: Reference Ranges for C-Terminal Telopeptide of Type I Collagen and Procollagen I N-Terminal Peptide by Age and Gender
por: Li, Mei, et al.
Publicado: (2014)

Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastases
por: Aufderklamm, Stefan, et al.
Publicado: (2021)

The ZOTECT study: Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer
por: Hadji, Peyman, et al.
Publicado: (2012)

Relationship Between Urinary Cross-Linked N-Telopeptide of Type-I Collagen and Heel Stiffness Index Measured by Quantitative Ultrasound in Middle-Aged and Elderly Men
por: Nishimura, Takayuki, et al.
Publicado: (2015)

Effects of zoledronic acid and ibandronate in the treatment of cancer pain in rats with lung cancer combined with bone metastases
por: Wang, Gengshen, et al.
Publicado: (2018)

Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
por: Rader, Michael, et al.
Publicado: (2012)

Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
por: Xie, Jipan, et al.
Publicado: (2011)

Modelling cancer outcomes of bone metastatic patients: combining survival data with N-Telopeptide of type I collagen (NTX) dynamics through joint models
por: Loureiro, Hugo, et al.
Publicado: (2019)

A Pilot Study of Cancer-Induced Bone Pain Using Validated Owner Questionnaires, Serum N-Telopeptide Concentration, Kinetic Analysis, and PET/CT
por: Flesner, Brian K., et al.
Publicado: (2021)

Serum cross‐linked N‐telopeptide of type I collagen as a potential diagnostic marker for bone metastasis in lung cancer: An updated meta‐analysis
por: Wang, Haiyan, et al.
Publicado: (2023)

Correlation between Urine N-Terminal Telopeptide and Fourier Transform Infrared Spectroscopy Parameters: A Preliminary Study
por: Okano, Ichiro, et al.
Publicado: (2020)

The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel
por: Jagdev, S P, et al.
Publicado: (2001)

The effect of zoledronate during bone healing
por: Matos, Marcos Almeida, et al.
Publicado: (2010)

The anti-tumour effects of zoledronic acid
por: Zekri, Jamal, et al.
Publicado: (2014)

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases
por: Lam, Marnix G. E. H., et al.
Publicado: (2007)

Efficacy of combination therapy with zoledronic acid and cetuximab for unresectable rectal cancer with bone metastases: A case report
por: Tokumaru, Yoshihisa, et al.
Publicado: (2019)

Serum Bone Resorption Markers after Parathyroidectomy for Renal Hyperparathyroidism: Correlation Analyses for the Cross-Linked N-telopeptide of Collagen I and Tartrate-Resistant Acid Phosphatase
por: Hung, Kuo-Chin, et al.
Publicado: (2012)

Gingival Crevicular Fluid Calprotectin, Osteocalcin and Cross-Linked N-Terminal Telopeptid Levels in Health and Different Periodontal Diseases
por: Becerik, Sema, et al.
Publicado: (2011)

Calprotectin and N-telopeptide of Type I Collagen (NTx) as Gingival Crevicular Fluid (GCF) Biomarker in Peri-Implantitis Patients
por: Swarup, Siddharth, et al.
Publicado: (2022)

Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases
por: Generali, D, et al.
Publicado: (2008)

Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer
por: Hilton, J.F., et al.
Publicado: (2017)

Expressions and clinical significance of serum bone Gla-protein, bone alkaline phosphatase and C-terminal telopeptide of type I collagen in bone metabolism of patients with osteoporosis
por: Zhao, Dongfeng, et al.
Publicado: (2015)

Zoledronic acid in the management of metastatic bone disease
por: Polascik, Thomas J, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_fsperc2vbsid3pl0neq6h5tgem